EGFR activation triggers signalling cascades, including the PI3K/Akt pathway [45], and its overexpression is common in many cancers including NPC, and is linked with tumour recurrence, migration, and poor prognosis in NPC [14–16, 46]. This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.